Trial site
Clinical NeuroScience Solutions Inc
- 10running trials
- 28closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Depression12 trials
- Alzheimer disease3 trials
- Migraine3 trials
- Bipolar disorder2 trials
- Insomnia2 trials
- Alopecia areata1 trial
- Atopic dermatitis (eczema)1 trial
- Essential tremor1 trial
- High blood pressure1 trial
- Obesity1 trial
- Obstructive sleep apnoea1 trial
- Parkinson disease1 trial
- Phase
- Phase 221 trials
- Phase 313 trials
- Phase 2/32 trials
- Phase 42 trials
- Status
- Completed22 trials
- Active, not recruiting7 trials
- Terminated6 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.4 trials
- Biohaven Pharmaceuticals, Inc.3 trials
- Jazz Pharmaceuticals3 trials
- Pfizer3 trials
- Biohaven Therapeutics Ltd.2 trials
- and 19 more
Running trials
Recruiting
Recruiting
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Active, not recruiting
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Recruiting
Active, not recruiting
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression2 recruiting
Closed trials
Completed
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
Terminated
Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
Completed
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
Completed
Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
Completed
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Completed
Completed
Completed
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
Completed
ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Completed
A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
Completed
Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
Completed
Completed
Completed
A Study of JNJ-55308942 in the Treatment of Bipolar Depression
Terminated
Completed
Completed
A Study of JZP150 in Adults With Posttraumatic Stress Disorder
Completed
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Completed
Completed
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
Completed
Terminated
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
Completed
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Completed
Completed
Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026